A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company.

Chemotherapy is a widely used treatment method in the field of oncology, aimed at treating cancer by administering drugs that kill rapidly dividing cells.

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.

Granulocyte colony-stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.

HIV/AIDS is a global pandemic caused by the human immunodeficiency virus (HIV).

Medication is a term used to describe any substance administered to a person or animal for the purpose of treating, curing, or preventing a medical condition.

Neutrophils are a type of white blood cell that play a crucial role in the immune response to infection.

The WHO Model List of Essential Medicines (EM) is a list published by the World Health Organization (WHO) that identifies the most essential medications needed in a basic health care system.